Boston University

Running trials

• Not yet recruiting

  Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance

  NCT07898592· Source

• Recruiting

  Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

  NCT07455760· Source

• Recruiting

  Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

  NCT05624931· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· Phase 3· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06589986· Phase 3· Source

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Source

• Enrolling by invitation

  Alzheimer's Plasma Extension

  NCT06416072· Source

• Enrolling by invitation

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· Source

• Recruiting

  Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

  NCT05734313· Source

• Active, not recruiting

  Telehealth for Pain and Unhealthy Drinking Among PLWH

  NCT05503173· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Source

• Recruiting

  Neural Mechanisms of Spatial Representations Beyond the Self

  NCT05406349· Source

• Active, not recruiting

  Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

  NCT05270668· Phase 2· Source

• Active, not recruiting

  A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

  NCT05071300· Phase 3· Source

• Active, not recruiting

  EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

  NCT04921787· Source

• Active, not recruiting

  Study in Parkinson Disease of Exercise

  NCT04284436· Source

• Active, not recruiting

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04961567· Phase 3· Source

• Active, not recruiting

  Metformin in Alzheimer's Dementia Prevention

  NCT04098666· Phase 2/3· Source

• Active, not recruiting

  AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  NCT04468659· Phase 3· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Amyloidosis2 recruiting
• Parkinson disease2 recruiting
• Autism1 recruiting
• Crohn's disease1 recruiting
• Epilepsy1 recruiting
• Frontotemporal dementia1 recruiting
• HIV1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

  NCT06182241· Source

• Completed

  A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

  NCT07174869· Source

• Completed

  Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior

  NCT06547320· Phase 2· Source

• Completed

  The Benefits of Nature for Mood and Cognition in Persons With and Without Parkinson's Disease

  NCT06483126· Source

• Completed

  Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning

  NCT06332144· Source

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Source

• Completed

  Development of a Family-Based Transition Planning Program for Culturally-Diverse Youth on the Autism Spectrum

  NCT05965648· Source

• Completed

  Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

  NCT05437159· Source

• Completed

  Perception in Parkinson's Disease

  NCT05483036· Source

• Completed

  Zambia Infant Cohort Study - Brains Optimized for Surviving and Thriving

  NCT05119959· Source

• Completed

  Neuroimaging Sleep and Mood in Depression

  NCT05497414· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Completed

  EXHIT ENTRE Comparative Effectiveness Trial

  NCT04345718· Phase 2/3· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Source

• Completed

  Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

  NCT04146428· Source

• Completed

  Couples Lived Experience

  NCT04863495· Source

• Completed

  Internet-based Video-conferencing to Address Alcohol Use and Pain: a Pilot Trial

  NCT04441593· Source

• Completed

  A Cluster Randomized Trial of the H2GO! Program

  NCT04265794· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· Source

• Recruiting

  Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

  NCT03004326· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Source

• Recruiting

  VCRC Tissue Repository

  NCT02967068· Source

• Completed

  Scleroderma Treatment With Autologous Transplant (STAT) Study

  NCT01413100· Phase 2· Source

Trial sites

• Boston University1 trial
• Boston University23 trials
• Boston University (Boston U)1 trial
• Boston University (Charles River Campus)2 trials
• Boston University School of Medicine10 trials
• Boston University School of Medicine (Site 4021)1 trial
• Boston University School of Public Health2 trials
• Charles River Campus, Boston University, Psychology Department- remote study1 trial
• General Clinical Research Unit, Boston University1 trial
• Vision and Cognition Laboratory, Boston University2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease414 works · 7 trials
• Stroke303 works · 0 trials
• HIV275 works · 4 trials
• Obesity149 works · 2 trials
• Heart failure144 works · 0 trials
• Tuberculosis123 works · 0 trials
• Type 2 diabetes83 works · 0 trials
• Chronic kidney disease66 works · 0 trials
• Atrial fibrillation62 works · 0 trials
• Amyloidosis59 works · 3 trials
• Parkinson disease58 works · 6 trials
• Asthma44 works · 0 trials
• Schizophrenia40 works · 0 trials
• Epilepsy37 works · 1 trials
• COPD32 works · 0 trials
• Coronary artery disease32 works · 0 trials
• Sickle cell disease30 works · 0 trials
• Autism28 works · 4 trials
• Cervical cancer21 works · 1 trials
• Idiopathic pulmonary fibrosis19 works · 0 trials
• Systemic sclerosis (scleroderma)18 works · 2 trials
• Head and neck cancer12 works · 0 trials
• ALS (motor neurone disease)11 works · 0 trials
• Ankylosing spondylitis9 works · 0 trials
• Long COVID and ME/CFS9 works · 1 trials
• Psoriatic arthritis7 works · 0 trials
• ANCA-associated vasculitis4 works · 2 trials